DNA X (SONM) Company Report

Peter Liu resigned from his positions as Chief Executive Officer and a Board member of DNA X, Inc. effective January 30, 2026, and will receive a total cash severance and bonus payment of $855,000.00.
Charles Becher resigned as General Manager of North America and Chief Commercial Officer effective January 29, 2026, and will receive a lump-sum cash severance payment of $250,000.00.
Both Mr. Liu and Mr. Becher will have their outstanding and unvested stock options accelerated and deemed fully vested as of their respective separation dates.
Scott Walker was appointed to the Board of Directors on January 30, 2026, following Mr. Liu's resignation, with his appointment made pursuant to DNA Holdings' director designation right.

3 hours ago

8-K

Sonim Technologies Rebrands to DNA X, Inc. and Shifts Focus to Digital Asset Management

SONM

M&A

New Projects/Investments

Sonim Technologies has rebranded as DNA X, Inc., effective January 23, 2026, concurrent with the completion of the asset sale of its rugged mobile phone business to NEXA®.
The company will now operate DNA X, a digital asset trading platform acquired in December 2025, marking a strategic shift to digital asset management operations.
Proceeds from the asset sale are anticipated to fund debt retirement and provide working capital for the new business, resulting in approximately $6.2 million of Post-Closing Cash.
While the Nasdaq trading symbol will temporarily remain SONM, a transition to DNAX is planned for the near future.

Jan 27, 2026, 10:00 PM

8-K

Sonim Technologies Announces Convertible Note Issuance and Equity Transactions

SONM

Debt Issuance

M&A

Convertible Preferred Issuance

Sonim Technologies, Inc. (SONM) entered into a Securities Purchase Agreement and a Membership Interest Purchase Agreement with DNA Holdings Venture, Inc. on December 15, 2025, which included the issuance of 223,201 shares of common stock to DNA Holdings in exchange for membership interest in DNA X.
As part of this transaction, SONM issued a Convertible Promissory Note to DNA Holdings, dated December 15, 2025, maturing on December 15, 2026, bearing 10% interest per annum (increasing to 20% upon default), and convertible into common stock at an initial price of $5.50 per share. DNA Holdings also holds a Put Option until June 30, 2026, contingent on DNA X achieving specific trading volume or revenue targets.
The company also engaged in an Exchange Agreement with Streeterville Capital, LLC on December 16, 2025, which involved partitioning a $629,640 secured promissory note and issuing 148,500 shares of common stock in exchange for this amount of the Note. Additionally, between October 6, 2025, and December 3, 2025, SONM issued a total of 88,654 shares of common stock to Streeterville Capital, LLC in exchange for $810,000 of the Note.

Dec 18, 2025, 1:55 PM

8-K

Sonim Technologies Announces Third Quarter 2025 Financial Results and Strategic Updates

SONM

Earnings

M&A

Delisting/Listing Issues

Sonim Technologies reported net revenue of $16.2 million for Q3 2025, marking a 45% sequential increase from Q2 2025, alongside a GAAP net loss of $4.8 million and Adjusted EBITDA of negative $2.0 million.
The company entered into a definitive agreement to sell substantially all of its assets to NEXA Mobility for $15.0 million in cash and up to $5.0 million in an earn-out payment, with the transaction expected to close late in the fourth quarter of 2025.
To regain compliance with Nasdaq listing requirements, stockholders approved a 1-for-18 reverse stock split, which became effective on October 27, 2025, and also approved an increase of authorized shares to 1 billion.
Key product launches during Q3 2025 included the Sonim MegaConnect 5G HPUE hotspot with AT&T and FirstNet, and the Sonim XP Pro with T-Mobile in the United States, and Bell, Rogers, and Telus in Canada.

Oct 31, 2025, 12:05 PM

8-K

Sonim Technologies Announces 1-for-18 Reverse Stock Split

SONM

Proxy Vote Outcomes

Delisting/Listing Issues

Sonim Technologies, Inc. (SONM) announced that its Board of Directors approved a 1-for-18 reverse stock split.
The reverse stock split will become effective at 12:01 a.m. Eastern Time on October 27, 2025.
The company's common stock is expected to commence trading on a split-adjusted basis on the Nasdaq Capital Market when markets open on October 27, 2025, under the existing symbol "SONM".
Stockholders will receive cash in lieu of fractional shares based on the closing price on October 20, 2025.

Oct 24, 2025, 12:00 PM

8-K

Sonim Technologies Announces Nasdaq Compliance Extension, Reverse Stock Split, Authorized Share Increase, and Executive Appointment

SONM

Delisting/Listing Issues

Proxy Vote Outcomes

Management Change

Sonim Technologies, Inc. received an extension until December 31, 2025, to regain compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million.
Stockholders approved an increase in authorized common stock from 100,000,000 to 1,000,000,000 shares, and the Board approved a 1-for-18 reverse stock split, expected to be effective on October 27, 2025, to aid Nasdaq compliance.
Michael Mulica was appointed Executive Chairman of the Board effective October 16, 2025, with an annual base salary of $300,000 and equity awards including an annual RSU grant of $250,000 and an Asset Purchase Award of $500,000 in RSUs.
Stockholders did not approve an amendment to the 2019 Equity Incentive Plan to increase the aggregate number of shares authorized for issuance by 1,000,000 shares.

Oct 20, 2025, 8:05 PM

8-K

Sonim Technologies Enters $500 Million Equity Purchase Agreement with Chardan Capital Markets

SONM

Sonim Technologies, Inc. (SONM) entered into a ChEF Purchase Agreement with Chardan Capital Markets LLC on September 29, 2025, allowing the company to sell up to $500,000,000 in aggregate gross purchase price of newly issued shares of common stock to the investor.
Under the terms of the agreement, Chardan Capital Markets LLC is obligated to purchase shares from the company upon the delivery of VWAP Purchase Notices or Intraday VWAP Purchase Notices.
The Purchase Agreement has a maximum commitment of $500,000,000 and can be terminated by Sonim Technologies at any time after Commencement with ten (10) trading days' prior written notice, at no cost or penalty.
Sonim Technologies acknowledges that the issuance of shares under this agreement could cause dilution to existing stockholders and significantly increase the outstanding number of common stock shares.

Sep 29, 2025, 8:05 PM

8-K

Sonim Technologies Notifies of Nasdaq Listing Deficiency

SONM

Delisting/Listing Issues

Sonim Technologies, Inc. (SONM) received a Nasdaq deficiency letter on August 22, 2025, indicating non-compliance with continued listing requirements.
The company's stockholders' equity was $1,334,000 as of June 30, 2025, which is below the Nasdaq Capital Market's required $2.5 million minimum.
SONM also did not meet alternative listing standards of $35.0 million in market value of listed securities or $0.5 million in net income from continuing operations.
The company has 45 calendar days, until October 6, 2025, to submit a plan to regain compliance, with a potential extension of up to 180 calendar days if the plan is accepted.